- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01167556
Family Motivational Intervention in Schizophrenia (FMI)
Motivational Interviewing and Interaction Skills Training for Carers to Change Cannabis Use in Young Adults With Recent-onset Schizophrenia: Randomised Controlled Trial
Cannabis use by people with schizophrenia is associated with family distress and poor clinical outcomes. Therefore, an Family Motivational Intervention (FMI) was developed to help parents to motivate their child with a diagnoses of recent-onset schizophrenia to reduce cannabis use.
In a single-blind randomised clinical trail with 75 patients with the diagnosis of schizophrenia, parents will be assigned to either FMI or to routine care. Assessments will be conducted at baseline and at a 10- and 22-month follow-up. The study hypothesis is that FMI will be more effective than routine care in reducing (a) cannabis use in patients and (b) distress and sense of burden in parents.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
North Holland
-
Amsterdam, North Holland, Netherlands, 1066 DP
- Academic Medical Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Clinical diagnosis of schizophrenia or psychotic-related disorder
- Onset of schizophrenia or related disorder within pervious the 10 years
- Cannabis use at least 2 days per week in the 3 months prior to the assessment
- Antipsychotic medication in prescribed or indicated
- At least 10 hours of contact with the parents each week in the last month
Exclusion Criteria:
-
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Family Motivational Intervention
An intervention provided to parents consisting of 6 sessions of training in Interactions Skills and 6 sessions training in Motivational Interviewing.
|
A intervention with provided parents 6 sessions of Interaction Skills training and 6 sessions Motivational Interviewing training.
|
|
Active Comparator: Routine care for parents
Routine care for parents consisting of 2 sessions psycho-education and individual support
|
A intervention with provided parents 6 sessions of Interaction Skills training and 6 sessions Motivational Interviewing training.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Cannabis use in patients with a diagnosis of recent-onset schizophrenia
Time Frame: Baseline (before the start of the intervention)
|
Baseline (before the start of the intervention)
|
|
Cannabis use in patients with a diagnosis of recent-onset schizophrenia
Time Frame: 10-month follow-up (3 months after the intervention has ended)
|
10-month follow-up (3 months after the intervention has ended)
|
|
Cannabis use in patients with a diagnosis of recent-onset schizophrenia
Time Frame: 22-month follow-up (15 months after the intervention has ended)
|
22-month follow-up (15 months after the intervention has ended)
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Medication adherence in patients with a diagnosis of recent-onset schizophrenia
Time Frame: Baseline (before the start of the intervention)
|
Baseline (before the start of the intervention)
|
|
Medication adherence in patients with a diagnosis of recent-onset schizophrenia
Time Frame: 10-month follow-up (3 months after the intervention has ended)
|
10-month follow-up (3 months after the intervention has ended)
|
|
Medication adherence in patients with a diagnosis of recent-onset schizophrenia
Time Frame: 22-month follow-up (15 months after the intervention has ended)
|
22-month follow-up (15 months after the intervention has ended)
|
|
Quality of life in patients with recent-onset schizophrenia
Time Frame: Baseline (before the start of the intervention)
|
Baseline (before the start of the intervention)
|
|
Quality of life in patients with recent-onset schizophrenia
Time Frame: 10-month follow-up (3 months after the intervention has ended)
|
10-month follow-up (3 months after the intervention has ended)
|
|
Quality of life in patients with recent-onset schizophrenia
Time Frame: 22-month follow-up (15 months after the intervention has ended)
|
22-month follow-up (15 months after the intervention has ended)
|
|
Stress in parents due to caring for a child with recent-onset schizophrenia
Time Frame: Baseline (before the start of the intervention)
|
Baseline (before the start of the intervention)
|
|
Stress in parents due to caring for a child with recent-onset schizophrenia
Time Frame: 10-month follow-up (3 months after the intervention has ended)
|
10-month follow-up (3 months after the intervention has ended)
|
|
Stress in parents due to caring for a child with recent-onset schizophrenia
Time Frame: 22-month follow-up (15 months after the intervention has ended)
|
22-month follow-up (15 months after the intervention has ended)
|
|
Expressed emotion in parents of patients with recent-onset schizophrenia
Time Frame: Baseline (before the start of the intervention)
|
Baseline (before the start of the intervention)
|
|
Expressed emotion in parents of patients with recent-onset schizophrenia
Time Frame: 10-month follow-up (3 months after the intervention has ended)
|
10-month follow-up (3 months after the intervention has ended)
|
|
Expressed emotion in parents of patients with recent-onset schizophrenia
Time Frame: 22-month follow-up (15 months after the intervention has ended)
|
22-month follow-up (15 months after the intervention has ended)
|
Collaborators and Investigators
Investigators
- Study Director: Gerard Schippers, Prof. dr., Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
- Principal Investigator: Don Linszen, Prof.dr., Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
- Study Chair: Lieuwe de Haan, Dr., Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Grant 100003014
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Schizophrenia
-
First Affiliated Hospital of Fujian Medical UniversityNot yet recruiting
-
Fundació Institut de Recerca de l'Hospital de la...Recruiting
-
Organon and CoCompletedSchizophrenia, Paranoid | Schizophrenia, Disorganized | Schizophrenia, Undifferentiated
-
Newron Pharmaceuticals SPARecruitingTreatment-resistant SchizophreniaUnited States, India
-
Organon and CoCompletedSchizophrenia, Paranoid | Schizophrenia, Disorganized | Schizophrenia, Undifferentiated
-
Bradley LegaRecruiting
-
All India Institute of Medical Sciences, BhubaneswarCompletedTreatment Resistant SchizophreniaIndia
-
Shanghai Zhongze Therapeutics Co., Ltd.Yale UniversityNot yet recruiting
-
Ole Köhler-ForsbergAarhus University HospitalRecruiting
-
University of California, Los AngelesNational Institute of Mental Health (NIMH)Recruiting
Clinical Trials on Family Motivational Intervention
-
Children's Hospital Medical Center, CincinnatiNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Completed
-
University of South CarolinaEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompleted
-
University of MiamiCompleted
-
Brown UniversityCompletedAdolescent Substance UseUnited States
-
St. Joseph's Healthcare HamiltonHamilton Academic Health Sciences OrganizationCompleted
-
Adiyaman UniversityNot yet recruitingContraceptionTurkey (Türkiye)
-
Brown UniversityNational Institute on Drug Abuse (NIDA)CompletedMarijuana Abuse | Substance Abuse | Alcohol Abuse | Adolescent Problem Behavior | Truancy; Socialized | Truancy; UnsocializedUnited States
-
Igdir UniversityKafkas UniversityRecruiting
-
San Diego State UniversityCompletedDrug AbuseUnited States
-
Mental Health Services in the Capital Region, DenmarkTrygFonden, Denmark; Sektion for Tværsektoriel forskning - Region HovedstadenActive, not recruitingChild | Parenting | Resilience | Mental Disorder | Prevention | FamilyDenmark